DiscoverInner Cosmos with David EaglemanEp 97 "Can we rewrite the human code?" (with Trevor Martin)
Ep 97 "Can we rewrite the human code?" (with Trevor Martin)

Ep 97 "Can we rewrite the human code?" (with Trevor Martin)

Update: 2025-03-24
Share

Digest

This podcast delves into the world of CRISPR gene editing, starting with an introduction to the technology and its revolutionary potential in medicine and genetics. It then traces the history of gene editing, highlighting the significance of the discovery of DNA's double helix structure and its implications for manipulating genes. A key part of the podcast features an interview with Trevor Martin of Mammoth Biosciences, discussing their work on developing smaller, more efficient CRISPR systems for gene editing and diagnostics. The challenges of delivering CRISPR systems to various cells and the ethical considerations surrounding gene editing are explored in detail. Finally, the podcast examines the potential impact of gene editing on longevity and healthspan, addressing the ethical concerns of human enhancement and the potential for societal inequalities based on access to these technologies. The discussion includes the complexities of treating polygenic diseases and the long-term consequences of altering the human genome.

Outlines

00:00:00
Introduction to CRISPR and Gene Editing

This introductory section covers CRISPR technology, its potential to revolutionize medicine and genetics, and previews an interview with Mammoth Biosciences' CEO.

00:02:10
A Brief History of Gene Editing

This section explores the historical context of gene editing, from the discovery of DNA's double helix to the development of current technologies, emphasizing the relatively recent nature of this field and its profound implications.

00:07:51
Mammoth Biosciences and CRISPR Innovation

An interview with Trevor Martin of Mammoth Biosciences details their work on developing smaller, more efficient CRISPR systems for gene editing and diagnostics, addressing challenges in delivery and ethical considerations.

00:43:00
Gene Editing, Longevity, and Ethical Implications

This section discusses the potential impact of gene editing on longevity and healthspan, exploring the ethical considerations of human enhancement and the potential for societal stratification due to unequal access to these technologies. It also touches upon the challenges of treating complex polygenic diseases.

Keywords

CRISPR


A revolutionary gene-editing technology derived from a bacterial defense mechanism, enabling precise DNA modification with applications in disease treatment and agriculture.

Gene Editing


The process of altering an organism's genetic material, raising ethical considerations due to its potential impact on future generations.

Mammoth Biosciences


A biotechnology company developing next-generation CRISPR-based products for gene editing and diagnostics, focusing on smaller, more efficient systems.

Polygenic Diseases


Complex diseases caused by multiple genes, presenting significant challenges for gene editing therapies.

Healthspan


The duration of life spent in good health, potentially extendable through gene editing targeting age-related diseases.

Genome Editing


Direct manipulation of an organism's genome using technologies like CRISPR, offering potential cures for genetic diseases.

Gene Therapy


Using gene editing to treat or prevent diseases by modifying genes within a patient's cells.

Ethical Implications of Gene Editing


The moral and societal considerations surrounding gene editing, including access, enhancement vs. therapy, and long-term consequences.

Q&A

  • What are the main challenges in using CRISPR technology for gene editing?

    Delivering CRISPR systems to target cells, especially in the brain, and determining optimal edits for complex polygenic diseases are major hurdles. System size also limits delivery.

  • What are the ethical implications of gene editing, particularly concerning enhancement rather than disease treatment?

    Potential societal stratification based on access, blurring lines between therapy and enhancement, and long-term consequences of altering the human genome are significant ethical concerns.

  • What is the potential timeline for widespread application of CRISPR technology in treating various diseases?

    While used for some blood disorders, widespread application to other diseases, especially those affecting the brain, will likely take 5-10 years or more due to complexity, particularly with polygenic diseases.

  • How might gene editing impact our understanding of personal identity and human motivation?

    Gene editing could fundamentally alter our understanding of personal identity and societal values, potentially diminishing the importance of physical attributes as status symbols.

Show Notes

You're defined in part by the genome you arrive with -- so what does it mean when you can edit it? What does this have to do with viruses, copy-pasting, and whether we will modify the story of our own species? Join Eagleman with guest Trevor Martin, CEO of Mammoth Biosciences, for this week's episode about the remarkable situation we find ourselves in, now that we know how to read and write our biological inheritance. 

Comments 
In Channel
loading

Table of contents

00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep 97 "Can we rewrite the human code?" (with Trevor Martin)

Ep 97 "Can we rewrite the human code?" (with Trevor Martin)

iHeartPodcasts